Manipal Health Q2 FY27 results: net profit falls 10.32% on exceptional items, revenue rises 37.32%

Manipal Health Enterprises Ltd reported a fall in consolidated net profit for the July-September quarter. Profit dropped 10.32 per cent to Rs 284.98 crore, compared with Rs 317.78 crore a year earlier. The company linked the decline to exceptional items, as it released its first quarterly results after listing in August.

Representative image

Revenue from operations climbed 37.32 per cent to Rs 3,399.35 crore in the second quarter of FY27. It was Rs 2,475.42 crore in the same period last year. Total expenses also increased, reaching Rs 3,032.34 crore from Rs 2,110.71 crore a year earlier, according to an exchange filing.

Manipal Health net profit hit by exceptional items

The filing showed exceptional items expenditure of Rs 95.2 crore during the quarter. This included one-time fees of Rs 80 crore tied to early repayment of non-convertible debentures. The company said these costs weighed on the quarter’s bottom line despite higher operating income.

Manipal Health said operating performance stayed firm during the quarter. The hospital network pointed to steady patient demand and growth in high-acuity specialities. It also cited capacity absorption across facilities. The company added that stronger occupancy and better operating efficiencies supported results across the expanded network.

Manipal Health IPO details and listing timeline

During the quarter ended September, the company completed an initial public offering of over 15 crore equity shares. The issue price was Rs 590 per share. The IPO included a fresh issuance of 13,56,19,881 equity shares aggregating to Rs 8,000 crore and an offer for sale of 2,16,13,834 equity shares amounting to Rs 1,275 crore.

The company made its debut on the BSE and NSE on August 5. It said the quarterly update was its first set of results since listing. Shares of the company closed 0.48 per cent higher at Rs 680 apiece on the BSE.

Manipal Health expansion plans and bed addition roadmap

Manipal Hospitals Managing Director & CEO Dilip Jose said, We are pleased that our performance this quarter has been driven by volumes, with more patients accessing our care, and this, we believe, is the sustainable option for growth in care delivery. Improved capacity utilisation, particularly in high-acuity specialities, continued to be a key driver while maintaining focus on strengthening our clinical capabilities, improving operational performance and building a more integrated healthcare platform.

During the post-earnings call, Jose said the hospital network plans to add over 400 beds during the second half of the financial year. Jose added that major bed additions will happen FY29 onwards. Separately, COO Karthik Rajagopal said the company will keep investing in tier-II and tier-III cities.

Manipal Health also told exchanges it has completed the acquisition of Kinder Womens Hospital and Fertility Centre in Bengaluru. The company’s update combined the acquisition news with its quarterly numbers and expansion plans. It also reiterated that demand trends and capacity use supported the broader performance during the period.

With inputs from PTI